Literature DB >> 3358884

Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.

P J Neuvonen1, K Kivistö, E L Hirvisalo.   

Abstract

1. The interference of resins and activated charcoal with the absorption of digoxin, carbamazepine and frusemide was studied. 2. In a cross-over study consisting of four phases, single doses of colestipol hydrochloride (10 g), cholestyramine (8 g), activated charcoal (8 g) or water only were given to six healthy volunteers immediately after the simultaneous ingestion of digoxin (0.25 mg), carbamazepine (400 mg) and frusemide (40 mg). Plasma and urine concentrations of the test drugs and the urine volumes were determined up to 72 h. 3. The absorption of digoxin was not reduced by colestipol, moderately (30-40%, P less than 0.05) reduced by cholestyramine and greatly (96%) by charcoal. 4. The absorption of carbamazepine was not decreased by cholestyramine, slightly (10%) by colestipol and greatly (90%) by activated charcoal. 5. The absorption and the diuretic effect of frusemide were significantly diminished by all agents. The bioavailability was reduced by colestipol 80%, by cholestyramine 95% and by activated charcoal 99.5%. 6. The interference with the gastrointestinal absorption of most of the basic drugs by colestipol and cholestyramine seems to be minimal. On the other hand, the resins may seriously impair the absorption of certain acidic drugs, for example frusemide.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3358884      PMCID: PMC1386478          DOI: 10.1111/j.1365-2125.1988.tb03295.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Measurement of carbamazepine and its epoxide metabolite by high-performance liquid chromatography, and a comparison of assay techniques for the analysis of carbamazepine.

Authors:  G W Mihaly; J A Phillips; W J Louis; F J Vajda
Journal:  Clin Chem       Date:  1977-12       Impact factor: 8.327

2.  Effect of activated charcoal on hypercholesterolaemia.

Authors:  P Kuusisto; H Vapaatalo; V Manninen; J K Huttunen; P J Neuvonen
Journal:  Lancet       Date:  1986-08-16       Impact factor: 79.321

3.  The effect of colestipol on digitoxin plasma levels.

Authors:  R J van Bever; A M Duchateau; B F Pluym; F W Merkus
Journal:  Arzneimittelforschung       Date:  1976

Review 4.  Clinical pharmacokinetics of oral activated charcoal in acute intoxications.

Authors:  P J Neuvonen
Journal:  Clin Pharmacokinet       Date:  1982 Nov-Dec       Impact factor: 6.447

5.  Effect of activated charcoal on absorption and elimination of phenobarbitone, carbamazepine and phenylbutazone in man.

Authors:  P J Neuvonen; E Elonen
Journal:  Eur J Clin Pharmacol       Date:  1980-01       Impact factor: 2.953

6.  Treatment of Digoxin intoxication with colestipol.

Authors:  T L Kilgore; C R Lehmann
Journal:  South Med J       Date:  1982-10       Impact factor: 0.954

7.  Enhanced elimination of warfarin during treatment with cholestyramine.

Authors:  E Jähnchen; T Meinertz; H J Gilfrich; F Kersting; U Groth
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

8.  Reduction of absorption of digoxin, phenytoin and aspirin by activated charcoal in man.

Authors:  P J Neuvonen; S M Elfving; E Elonen
Journal:  Eur J Clin Pharmacol       Date:  1978-05-31       Impact factor: 2.953

9.  Cholestyramine and spironolactone and their combination in digitoxin elimination.

Authors:  S G Carruthers; C A Dujovne
Journal:  Clin Pharmacol Ther       Date:  1980-02       Impact factor: 6.875

10.  Interruption of the enterohepatic circulation of digitoxin by cholestyramine. I. Protection against lethal digitoxin intoxication.

Authors:  J H Caldwell; N J Greenberger
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

View more
  6 in total

1.  Effect of activated charcoal on frusemide induced diuresis: a human class experiment for medical students.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1990-09       Impact factor: 4.335

2.  The effect of cholestyramine and activated charcoal on glipizide absorption.

Authors:  K T Kivistö; P J Neuvonen
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

3.  Activated charcoal in the treatment of hypercholesterolaemia: dose-response relationships and comparison with cholestyramine.

Authors:  P J Neuvonen; P Kuusisto; H Vapaatalo; V Manninen
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Drug absorption related nephrotoxicity assessment on an intestine-kidney chip.

Authors:  Zhongyu Li; Wentao Su; Yujuan Zhu; Tingting Tao; Dong Li; Xiaojun Peng; Jianhua Qin
Journal:  Biomicrofluidics       Date:  2017-06-01       Impact factor: 2.800

5.  Effect of colesevelam HCl on single-dose fenofibrate pharmacokinetics.

Authors:  Michael R Jones; Brian A Baker; Philip Mathew
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 6.  Cardiovascular effects of noncardiovascular drugs.

Authors:  Satish R Raj; C Michael Stein; Pablo J Saavedra; Dan M Roden
Journal:  Circulation       Date:  2009-09-22       Impact factor: 29.690

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.